A comparative study on the outcomes of in vitro fertilization between women with polycystic ovary syndrome and those with sonographic polycystic ovary-only in GnRH antagonist cycles

Archives of Gynecology and Obstetrics

Volumn 282, Issue 2, 2010, Pages 199-205

  Kim, Yong Jin ^a   Ku, Seung Yup ^a   Jee, Byung Chul ^a   Suh, Chang Suk ^a   Kim, Seok Hyun ^a   Choi, Young Min ^a   Kim, Jung Gu ^a   Moon, Shin Yong ^a  

^a Seoul National University   (South Korea)

Author keywords

Controlled ovarian hyperstimulation; In vitro fertilization; Polycystic ovary syndrome; Sonographic polycystic ovary only

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; PROSTAGLANDIN E2; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; TRIPTORELIN; GONADORELIN; GONADOTROPIN;

ADULT; ADVERSE OUTCOME; ARTICLE; CELL COUNT; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REDUCTION; EMBRYO; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; NIDATION; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY OUTCOME; PREGNANCY RATE; RISK ASSESSMENT; TRANSVAGINAL ECHOGRAPHY; TREATMENT DURATION; WOMEN'S HEALTH; AGONISTS; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMICALLY INDUCED; ECHOGRAPHY; OOCYTE RETRIEVAL; OVARY; POLYCYSTIC OVARY SYNDROME; PREGNANCY; RETROSPECTIVE STUDY;

ADULT; DINOPROSTONE; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; OOCYTE RETRIEVAL; OVARIAN HYPERSTIMULATION SYNDROME; OVARY; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES;

EID: 77956453804     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-010-1401-9     Document Type: Article

References (30)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89 (6):2745-2749
2. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (pcos). Hum Reprod 19 (1):41-47
3. Carmina E, Chu MC, Longo RA, Rini GB, Lobo RA (2005) Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 90 (5):2545-2549
4. Balen AH, Laven JS, Tan SL, Dewailly D (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9 (6):505-514
5. Michelmore K, Ong K, Mason S, Bennett S, Perry L, Vessey M, Balen A, Dunger D (2001) Clinical features in women with polycystic ovaries: Relationships to insulin sensitivity, insulin gene vntr and birth weight. Clin Endocrinol (Oxf) 55 (4):439-446
6. Schenker JG (1993) Prevention and treatment of ovarian hyperstimulation. Hum Reprod 8 (5):653-659
7. Hatch R, Rosenfield RL, Kim MH, Tredway D (1981) Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140 (7):815-830
8. Lee JR, Kim SH, Kim SM, Jee BC, Ku SY, Suh CS, Choi YM, Kim JG, Moon SY (2008) Follicular fluid anti-mullerian hormone and inhibin b concentrations: comparison between gonadotropinreleasing hormone (gnrh) agonist and gnrh antagonist cycles. Fertil Steril 89 (4):860-867
9. Moon SY, Choi YS, Ku SY, Kim SH, Choi YM, Kang IS, Kim CH (2007) Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (da-3801) with follitropin-alpha (Gonal-f) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology. J Obstet Gynaecol Res 33 (3):305-315
10. Veeck LL (1988) Oocyte assessment and biological performance. Ann NY Acad Sci 541:259-274
11. The Practice Committee of the American Society for Reproductive Medicine (2004) Ovarian hyperstimulation syndrome. Fertil Steril 82 (Suppl 1): S81-S86
12. Kolibianakis EM, Papanikolaou EG, Tournaye H, Camus M, Van Steirteghem AC, Devroey P (2007) Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone. Fertil Steril 88 (5):1382-1388
13. Lainas TG, Petsas GK, Zorzovilis IZ, Iliadis GS, Lainas GT, Cazlaris HE, Kolibianakis EM (2007) Initiation of gnrh antagonist on day 1 of stimulation as compared to the long agonist protocol in pcos patients. A randomized controlled trial: effect on hormonal levels and follicular development. Hum Reprod 22 (6):1540-1546
14. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22 (1):141-146
15. Esmailzadeh S, Faramarzi M, Jorsarai G (2005) Comparison of in vitro fertilization outcome in women with and without sonographic evidence of polycystic ovarian morphology. Eur J Obstet Gynecol Reprod Biol 121 (1):67-70
16. Jung JH, Kim SH, Suh CS, Choi YM, Shin CJ, Kim JG, Moon SY, Lee JY (1997) Outcome of in vitro fertilization and embryo transfer in patients with multifollicular ovarian pattern in transvaginal ultrasonography. Korean J Obstet Gynecol 40 (5):1002-1012
17. Esinler I, Bayar U, Bozdag G, Yarali H (2005) Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries. Fertil Steril 84 (4):932-937
18. Sahu B, Ozturk O, Ranierri M, Serhal P (2008) Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome. Arch Gynecol Obstet 277 (3):239-244
19. Griesinger G, Diedrich K, Tarlatzis BC, Kolibianakis EM (2006) Gnrh-antagonists in ovarian stimulation for ivf in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online 13 (5):628-638
20. Hwang JL, Seow KM, Lin YH, Huang LW, Hsieh BC, Tsai YL, Wu GJ, Huang SC, Chen CY, Chen PH, Tzeng CR (2004) Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study. Hum Reprod 19 (9):1993-2000
21. Bahceci M, Ulug U, Ben-Shlomo I, Erden HF, Akman MA (2005) Use of a gnrh antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study. J Reprod Med 50 (2):84-90
22. Choi JW, Kim CH, Lee HA, Hong SH, Nah HY, Lee YJ, Kim SH, Chae HD, Son YS, Kang BM (2005) Efficacy of controlled ovarian hyperstimulation using gnrh antagonist in women with polycystic ovary syndrome undergoing ivf-et. Korean J Obstet Gynecol 48 (3):716-725
23. Kurzawa R, Ciepiela P, Baczkowski T, Safranow K, Brelik P (2008) Comparison of embryological and clinical outcome in gnrh antagonist vs. Gnrh agonist protocols for in vitro fertilization in pcos non-obese patients. A prospective randomized study. J Assist Reprod Genet 25 (8):365-374
24. Orvieto R, Nahum R, Meltcer S, Homburg R, Rabinson J, Anteby EY, Ashkenazi J (2009) Ovarian stimulation in polycystic ovary syndrome patients: the role of body mass index. Reprod Biomed Online 18 (3):333-336
25. Cho LW, Jayagopal V, Kilpatrick ES, Holding S, Atkin SL (2006) The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome. Ann Clin Biochem 43 (Pt 3):217-219
26. Wei HJ, Young R, Kuo IL, Liaw CM, Chiang HS, Yeh CY (2009) Prevalence of insulin resistance and determination of risk factors for glucose intolerance in polycystic ovary syndrome: a crosssectional study of Chinese infertility patients. Fertil Steril 91 (5):1864-1868
27. Yilmaz N, Pektas M, Tonguc E, Kilic S, Gulerman C, Gungor T, Mollamahmutoglu L (2008) The correlation of plasma homocysteine with insulin resistance in polycystic ovary syndrome. J Obstet Gynaecol Res 34 (3):384-391
28. Sayin NC, Gucer F, Balkanli-Kaplan P, Yuce MA, Ciftci S, Kucuk M, Yardim T (2003) Elevated serum TNF-alpha levels in normalweight women with polycystic ovaries or the polycystic ovary syndrome. J Reprod Med 48 (3):165-170
29. Adams JM, Taylor AE, Crowley WF Jr, Hall JE (2004) Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab 89 (9):4343-4350
30. Chae SJ, Kim JJ, Choi YM, Hwang KR, Jee BC, Ku SY, Suh CS, Kim SH, Kim JG, Moon SY (2008) Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Hum Reprod 23 (8):1924-1931